The emerging treatment of this peptide represents a exciting breakthrough in the care of type 2 diabetes. Unlike existing therapies, tirzepatide affects two pathways – the GLP-1 hormone and GIP – resulting in https://tirzepatide-peptide646263.blogdemls.com/41819504/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment